NeuroScience | Kavinace Ultra PM | 30 Capsules

NeuroScience

$ 56.00 

Kavinace Ultra PM | 30 Capsules:

Dietary Supplement!

Blend of ingredients shown to improve onset and quality of sleep*

Kavinace Ultra PM provides the strongest sleep support among Kavinace products*

  • GABA is the primary inhibitory neurotransmitter in the brain, which means it plays a central role in balancing the excitability of neurons (1). Because of this reason, GABA is important for promoting sleep, calm, and managing stress (2-4). Stress is thought to alter GABA synthesis and activity by affecting the expression of GABA-synthesizing enzymes and receptors (5).
  • The effects of Kavinace Ultra PM have been studied in a randomized, placebo-controlled study.
  • One capsule of Kavinace Ultra PM taken at bedtime for 5 days significantly improved quality of sleep as measured by the Pittsburgh Sleep Quality Index (6).* Participants taking Kavinace Ultra PM reported decreased time to fall asleep, increased duration of sleep, and decreased sleep disturbances (6).*

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

**Relative amounts of ingredients as compared to other Kavinace products.

Supplement Facts:

Serving Size: 1 Capsule
Servings Per Container: 30

Amount Per Serving:

Ingredient Amount % Daily Value
Melatonin 3 mg
Proprietary Blend
4-amino-3-phenylbutyric acid HCl and 5-hydroxytryptophan (from Griffonia simplicifolia seed extract)
650 mg

† Daily Value (DV) not established.

Suggested Use:

Take 1 capsule at bedtime as needed or as directed by your healthcare provider.

Other Ingredients:

Vegetable capsule (Hypromellose, water), Microcrystalline cellulose, and Magnesium stearate (vegetable source).

Notes/Warnings:

If you are pregnant or nursing, consult your healthcare provider before use.

References:

  1. Gou Z, et al. Dongwuxue Yanjiu. 2012;33(E5-6):E75-81.
  2. Mohler H. Neuropharmacology. 2012;62(1):42-53.
  3. Saper C, et al. Nature. 2005;437(7063):1257-63.
  4. Mody I and Maguire J. Front Cell Neurosci. 2012;6:4.
  5. Maguire J. Front Cell Neurosci. 2014;8:157.
  6. Data on file, 2011. NeuroScience, Inc., Osceola, WI 54020.